Mirum Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary

Mirum Pharmaceuticals

12/11/2024 15:30

* Mirum Pharmaceuticals Inc  MIRM.OQ  reported a quarterly
adjusted loss of 30 cents​​ per share for the quarter ended
September 30, higher than the same quarter last year, when the
company reported EPS of -57 cents.  The mean expectation of
ten analysts for the quarter was for a loss of 45 cents per
share. Wall Street expected results to range from -61 cents
to -30 cents per share.
    * Revenue rose 89.4% to $90.38 million from a year ago;
analysts
expected $82.02 million. 
    * Mirum Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 30 cents​.
    * The company reported a quarterly loss of $14.24 million.
    * Mirum Pharmaceuticals Inc shares had risen by 6.7% this
quarter and gained 41.0% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 4.2%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Mirum
Pharmaceuticals Inc is 65.50 
This summary was machine generated from LSEG data November 12 at
03:29 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jan. 1 0001       -0.45          -0.30          Beat
 Jun. 30 2024      -0.47          -0.52          Missed
 Mar. 31 2024      -0.48          -0.54          Missed
 Dec. 31 2023      -0.24          -0.66          Missed